Mainz Biomed B.V. Statistics
Total Valuation
MYNZ has a market cap or net worth of $7.42 million. The enterprise value is $6.74 million.
| Market Cap | 7.42M |
| Enterprise Value | 6.74M |
Important Dates
The next estimated earnings date is Tuesday, August 13, 2024, before market open.
| Earnings Date | Aug 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MYNZ has 21.89 million shares outstanding. The number of shares has increased by 14.73% in one year.
| Shares Outstanding | 21.89M |
| Shares Change (YoY) | +14.73% |
| Shares Change (QoQ) | +19.54% |
| Owned by Insiders (%) | 21.63% |
| Owned by Institutions (%) | 0.67% |
| Float | 18.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.29 |
| Forward PS | 3.65 |
| PB Ratio | 2.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 1.97.
| Current Ratio | 0.97 |
| Quick Ratio | 0.78 |
| Debt / Equity | 1.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.48 |
Financial Efficiency
Return on equity (ROE) is -488.00% and return on invested capital (ROIC) is -276.40%.
| Return on Equity (ROE) | -488.00% |
| Return on Assets (ROA) | -145.80% |
| Return on Capital (ROIC) | -276.40% |
| Revenue Per Employee | $13,777 |
| Profits Per Employee | -$404,550 |
| Employee Count | 65 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.08% in the last 52 weeks. The beta is 0.30, so MYNZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -93.08% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 31.42 |
| Average Volume (20 Days) | 382,652 |
Short Selling Information
The latest short interest is 282,164, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 282,164 |
| Short Previous Month | 425,662 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 1.53% |
| Short Ratio (days to cover) | 1.07 |
Income Statement
In the last 12 months, MYNZ had revenue of $895,479 and -$26.30 million in losses. Loss per share was -$1.62.
| Revenue | 895,479 |
| Gross Profit | 509,659 |
| Operating Income | -26.64M |
| Pretax Income | -26.30M |
| Net Income | -26.30M |
| EBITDA | -24.62M |
| EBIT | -25.49M |
| Loss Per Share | -$1.62 |
Balance Sheet
The company has $7.07 million in cash and $6.39 million in debt, giving a net cash position of $680,311 or $0.03 per share.
| Cash & Cash Equivalents | 7.07M |
| Total Debt | 6.39M |
| Net Cash | 680,311 |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 3.25M |
| Book Value Per Share | 0.15 |
| Working Capital | -257,148 |
Cash Flow
In the last 12 months, operating cash flow was -$21.94 million and capital expenditures -$1.90 million, giving a free cash flow of -$23.84 million.
| Operating Cash Flow | -21.94M |
| Capital Expenditures | -1.90M |
| Free Cash Flow | -23.84M |
| FCF Per Share | -$1.47 |
Margins
Gross margin is 56.91%, with operating and profit margins of -2,975.47% and -2,936.50%.
| Gross Margin | 56.91% |
| Operating Margin | -2,975.47% |
| Pretax Margin | -2,936.50% |
| Profit Margin | -2,936.50% |
| EBITDA Margin | -2,749.34% |
| EBIT Margin | -2,846.09% |
| FCF Margin | -2,662.00% |
Dividends & Yields
MYNZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.73% |
| Shareholder Yield | -14.73% |
| Earnings Yield | -354.41% |
| FCF Yield | -321.28% |
Analyst Forecast
The average price target for MYNZ is $3.00, which is 784.96% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.00 |
| Price Target Difference | 784.96% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 159.62% |
| EPS Growth Forecast (5Y) | -52.11% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MYNZ has an Altman Z-Score of -11.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.35 |
| Piotroski F-Score | 3 |